Ikarian Capital, LLC Vista Gen Therapeutics, Inc. Transaction History

Ikarian Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.88 - $1.73 $449,843 - $884,351	-511,186 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.14 - $2.09 $40,462 - $74,180	35,493 Added 7.46%	511,186 $633,000
Q4 2021 Feb 14, 2022	SELL	$1.67 - $2.76 $208,750 - $345,000	-125,000 Reduced 20.81%	475,693 $927,000
Q3 2021 Nov 15, 2021	SELL	$2.62 - $3.45 $827,550 - $1.09 Million	-315,859 Reduced 34.46%	600,693 $1.65 Million
Q2 2021 Aug 16, 2021	SELL	$1.96 - $3.15 $3.86 Million - $6.2 Million	-1,969,400 Reduced 68.24%	916,552 $2.89 Million
Q1 2021 May 17, 2021	SELL	$1.89 - $2.96 $3.02 Million - $4.74 Million	-1,600,000 Reduced 35.67%	2,885,952 $6.15 Million
Q4 2020 Feb 12, 2021	BUY	$0.65 - $1.94 $2.92 Million - $8.7 Million	4,485,952 New	4,485,952 $8.7 Million

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $544M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.